Search Results 8161-8170 of 28368 for oral
Best Clinical Vignette Oral PresentationScripps Geller Research Symposium. 2014. Best Original Investigation Poster PresentationScripps Geller Research ...
... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Research. Specialists at ...
Have impaired gastrointestinal (GI) function or GI disease that may significantly alter the absorption of oral infigratinib (e.g., active ulcerative ...
A Blanket Protocol to Study Oral Regorafenib in Patients with Selected Sarcoma Subtypes Jacksonville, FL; Rochester, MN. Regorafenib might or might not slow ...
Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk Information ...
Florida. Mayo Clinic awarded $5.3 million federal grant to study vascular risk factors in dementia. Kevin Punsky. November 12, 2015. Cancer. Prior Oral ...
Rhoda Madson, Mayo Clinic Public Affairs, newsbureau@mayo.edu · Mayo Clinic Q&A podcast: Advances in oral cancer treatment, reconstruction · Low-dose aspirin to ...
It is not yet known which regimen of chemotherapy is more effective for breast cancer. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical ...
Overview. Aging is the most powerful risk factor for cognitive impairment and dementia, yet the underlying biology is not fully understood.
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.